Liquid biopsy in breast cancer

作者：E. Klocker, Christoph Suppan · 发表于：memo - Magazine of European Medical Oncology · 年份：2024 · DOI：10.1007/s12254-024-00975-9 · 被引用次数：1

Currently, the main clinical application of liquid biopsy (LB) in breast cancer (BC) is the circulating tumor DNA (ctDNA)-based detection of treatment targets in metastatic or advanced disease. In this short review we focus on clinically relevant applications in BC and give a brief overview of potential future uses.